Advertisement

Topics

UPDATE 1-U.S. states sue opioid-maker Indivior, alleging anticompetitive practices

11:51 EDT 22 Sep 2016 | Reuters

WASHINGTON, Sept 22 (Reuters) - Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market.

Original Article: UPDATE 1-U.S. states sue opioid-maker Indivior, alleging anticompetitive practices

NEXT ARTICLE

More From BioPortfolio on "UPDATE 1-U.S. states sue opioid-maker Indivior, alleging anticompetitive practices"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...